home / stock / myl / myl news


MYL News and Press, Mylan N.V. From 08/19/20

Stock Information

Company Name: Mylan N.V.
Stock Symbol: MYL
Market: NASDAQ
Website: viatris.com

Menu

MYL MYL Quote MYL Short MYL News MYL Articles MYL Message Board
Get MYL Alerts

News, Short Squeeze, Breakout and More Instantly...

MYL - Mylan launches first generic to Tecfidera in multiple sclerosis

Mylan N.V. (NASDAQ: MYL ) announces  the launch of the first FDA-approved therapeutically equivalent, substitutable generic of Biogen's Tecfidera capsules. More news on: Mylan, Inc., Healthcare stocks news, Read more ...

MYL - Mylan Brings Critical Access to the Multiple Sclerosis Community by Launching a More Affordable Treatment Option Through a First Generic to Tecfidera®

HERTFORDSHIRE, England and PITTSBURGH , Aug. 19, 2020 /PRNewswire/ --  Mylan  N.V. (NASDAQ: MYL) today announced the launch of the first FDA-approved therapeutically equivalent, substitutable generic of Biogen's Tecfidera ® capsules. Dimethyl fumarate delayed releas...

MYL - FDA OKs Mylan's generic version of Biogen MS med Tecfidera

The FDA has approved Mylan's ( MYL -0.6% ) generic version of Biogen's ( BIIB -0.3% ) top seller Tecfidera (dimethyl fumarate). More news on: Mylan, Inc., Biogen Inc., Healthcare stocks news, Read more ...

MYL - Why Pfizer's 4% Yield Is Your Best Covid-19 Vaccine Play

Written by Robert Kovacs Introduction Back in May, I wrote an article in which I suggested that “ with or without a Covid-19 vaccine ”, Pfizer ( PFE ) was a buy. Since then the stock has dropped 15% and climbed back to the price it was a quarter ago. Pfizer is currently t...

MYL - Mylan and Sesame Workshop Partner to Provide Socio-Emotional Support Resources to Families Impacted by COVID-19

HERTFORDSHIRE, England, PITTSBURGH and NEW YORK , Aug. 12, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) and Sesame Workshop, the non-profit educational organization behind Sesame Street , today announced a new effort to help children and families cope with the ongoing transi...

MYL - Should Pfizer Be Your Next Coronavirus Buy?

The coronavirus pandemic has the world's drugmakers working together to deliver medical solutions and some companies are poised to contribute more than others. With a coronavirus vaccine candidate in late-stage clinical trials and a contract to help manufacture the only COVID-19 antiviral treatm...

MYL - Mylan: Treating Debt And Intangibles

In today's world, it is shortsighted to think that infectious diseases cannot cross borders. By allowing developing countries access to generic drugs, we not only help improve health in those nations, we also help ourselves control these debilitating and often deadly diseases. − Ron Wy...

MYL - Is Pfizer Stock a Buy?

The COVID-19 pandemic is creating many problems in the healthcare industry, from hospitals struggling to treat patients with the disease (and deferring elective procedures in the process) to patients foregoing necessary care. But it's also highlighting just how important, and essential, healthca...

MYL - Trump signs executive action to boost U.S. production of 'essential' drugs

"We will bring our pharmaceutical and medical supply chains home - we're going to bring them home where they belong - and we will end reliance on China," President Trump said during a visit to the Whirlpool manufacturing plant in Ohio. "We'll be making our product here - safely, beautifull...

MYL - Mylan N.V. (MYL) CEO Heather Bresch on Q2 2020 Results - Earnings Call Transcript

Mylan N.V. (MYL) Q2 2020 Results Conference Call August 06, 2020 10:30 AM ET Company Participants Melissa Trombetta - Head of Global Investor Relations Robert Coury - Chairman & Non-Executive Director Heather Bresch - Chief Executive Officer & Executive Director Rajiv M...

Previous 10 Next 10